2024 survey of the frequency of fixed-combination eye drop use by patients with glaucoma at multiple private practices in Japan
Japanese Journal of Ophthalmology · 2026
DOI: 10.1007/s10384-026-01368-7 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Japanese Journal of Ophthalmology, 2026. Verfasst von Kenji Inoue und 4 weiteren Autor:innen. Beteiligte Einrichtung: Inouye Eye Hospital, 4-3 Kanda-surugadai, Chiyoda-ku, Tokyo, 101-0062, Japan. inoue-k@inouye-eye.or.jp. Hauptthemen laut MEDLINE: Antihypertensive Agents, Glaucoma, Intraocular Pressure, Private Practice. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Purpose
To investigate the current (2024) use of fixed-combination eye drops in Japanese patients with glaucoma. Study design Cross-sectional survey.
Methods
The survey included 6323 outpatients (6323 eyes) with glaucoma or ocular hypertension at 82 private practices from March 10 to 16, 2024. The use of fixed-combination eye drops, including prostaglandin F (FP) receptor agonist/β-blocker (FP/β), carbonic anhydrase inhibitor/β-blocker (CAI/β), α2-adrenergic agonist/β-blocker (α2/β), α2-adrenergic agonist/carbonic anhydrase inhibitor (α2/CAI), and α2-adrenergic agonist/Rho-associated protein kinase (α2/ROCK), was analyzed, stratified by the number of medications used. The results were compared with those of a 2020 survey via χ^2 tests.
Results
FP/β, CAI/β, α2/β, α2/CAI, and α2/ROCK were used by respectively 56.4%, 8.0%, 2.2%, 2.9%, and 0.6% of 2-medication users; 42.5%, 30.2%, 3.2%, 11.2%, and 4.1% of 3-medication users; and 56.6%, 32.1%, 1.7%, 45.5%, and 14.4% of ≥4-medication users. FP/β were the most commonly used in all groups. Compared with the previous survey, the use of FP/β increased significantly in all groups, while that of CAI/β decreased significantly. Among four-medication users, 228 patients (44.4%) used two types of fixed-combination eye drops. In this group, FP/β + α2/CAI (186 cases) was the most common. Among five-medication users, 186 patients (69.9%) used two types of fixed-combination eye drops. In this group, FP/β + α2/CAI + one additional drug (131 cases) was the most common.
Conclusion
Fixed-combination eye drops were used in >70% of patients using 2 medications and >90% of patients using ≥3 medications. Over time, the use of FP/β increased, while the use of CAI/β decreased.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Inouye Eye Hospital, 4-3 Kanda-surugadai, Chiyoda-ku, Tokyo, 101-0062, Japan. inoue-k@inouye-eye.or.jp.
- Inouye Eye Hospital, 4-3 Kanda-surugadai, Chiyoda-ku, Tokyo, 101-0062, Japan.
- Nishikasai Inouye Eye Hospital, 3-12-14 Nishikasai, Edogawa-ku, Tokyo, 134-0088, Japan.
- Department of Ophthalmology, Toho University Ohashi Medical Center, 2-22-36 Ohashi, Meguro-ku, Tokyo, 153-8515, Japan.
Zitieren
APA
Inoue, K., Shiokawa, M., Kunimatsu-Sanuki, S., Tomita, G., & Ishida, K. (2026). 2024 survey of the frequency of fixed-combination eye drop use by patients with glaucoma at multiple private practices in Japan. Japanese Journal of Ophthalmology. https://doi.org/10.1007/s10384-026-01368-7
Vancouver
Inoue K, Shiokawa M, Kunimatsu-Sanuki S, Tomita G, Ishida K. 2024 survey of the frequency of fixed-combination eye drop use by patients with glaucoma at multiple private practices in Japan. Japanese Journal of Ophthalmology. 2026. doi:10.1007/s10384-026-01368-7
BibTeX
@article{Inoue2026,
author = {Inoue, Kenji and Shiokawa, Minako and Kunimatsu-Sanuki, Shiho and Tomita, Goji and Ishida, Kyoko},
title = {2024 survey of the frequency of fixed-combination eye drop use by patients with glaucoma at multiple private practices in Japan},
journal = {Japanese Journal of Ophthalmology},
year = {2026},
doi = {10.1007/s10384-026-01368-7}
}
EUVIMED